Background: The Bath Ankylosing Spondylitis Metrology Index (BASMI) characterises the spinal mobility of patients with ankylosing spondylitis. Two versions have been published using categorical scores with either scores 0–2 for each of the five assessments, or scores 0–10. For metric purposes, we recently defined a BASMI version with linear score definitions.
Aim: to evaluate agreement between three BASMI definitions and to test sensitivity to change.
Patients and methods: The performance of the BASMI2 (based on the 2-step definition), BASMI10 (based on the 10-step definition), and BASMIlin (based on the linear definition), are compared in 598 status assessments and 222 follow-up assessments with a 24-week interval after an intervention with either placebo or a tumour necrosis factor (TNF) blocker from various cohorts of patients with ankylosing spondylitis (AS). Descriptive statistics and Bland–Altman plots were applied to compare the pairwise agreement of the three definitions. To assess sensitivity to change, Guyatt effect size using change data from the placebo and actively treated patients were used.
Results: Bland–Altman analysis showed that the differences between BASMI2 scores and scores obtained by either of the two other definitions were highly dependent on the magnitude of the measurement. Guyatt effect sizes were 0.66 for the BASMI2, 0.95 for the BASMI10, and 1.04 for the BASMIlin, respectively, demonstrating best sensitivity to change for the newly-developed BASMIlin.
Conclusions: The BASMI10 and BASMIlin have clear metric advantages as compared to BASMI2, among which are their superior sensitivity to change and feasibility of BASMIlin in computer evaluations. The BASMI10 and BASMI2 are not interchangeable.
Statistics from Altmetric.com
Competing interests: None.